https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-06 / Biomedicines 2020 Mar;8(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-06 / Biomedicines 2020 Mar;8(3)2020-03-06 00:00:002021-11-15 17:52:40New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-01 / J Immunother Cancer 2020 03;8(1)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-01 / J Immunother Cancer 2020 03;8(1)2020-03-01 00:00:002022-09-29 14:17:36Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-02-26 / J Cell Mol Med 2020 04;24(7):4286-4297
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-02-26 / J Cell Mol Med 2020 04;24(7):4286-42972020-02-26 00:00:002022-09-29 14:03:50Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-02-22 / Cancer Immunol. Immunother. 2020 Jun;69(6):1015-1027
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-02-22 / Cancer Immunol. Immunother. 2020 Jun;69(6):1015-10272020-02-22 00:00:002020-08-26 14:19:05Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-02-01 / Transl Lung Cancer Res 2020 Feb;9(Suppl 1):S100-S119
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-02-01 / Transl Lung Cancer Res 2020 Feb;9(Suppl 1):S100-S1192020-02-01 00:00:002020-12-09 09:48:40Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-12-10 / Br. J. Cancer 2020 Jan;122(1):111-120
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-12-10 / Br. J. Cancer 2020 Jan;122(1):111-1202019-12-10 00:00:002019-12-10 00:00:00Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-11-01 / Int J Cancer 2020 01;146(2):531-541
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-11-01 / Int J Cancer 2020 01;146(2):531-5412019-11-01 00:00:002020-12-14 17:16:09Evaluation of Newcastle disease virus mediated dendritic cell activation and cross-priming tumor-specific immune responses ex vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-30 / Sci Rep 2019 Sep;9(1):13999
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-30 / Sci Rep 2019 Sep;9(1):139992019-09-30 00:00:002020-12-14 17:17:18Evaluation of a Recombinant Newcastle Disease Virus Expressing Human IL12 against Human Breast Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-27 / Front Mol Biosci 2019;6:90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-27 / Front Mol Biosci 2019;6:902019-09-27 00:00:002020-12-14 17:15:172-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-11 / Front Oncol 2019;9:884
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-11 / Front Oncol 2019;9:8842019-09-11 00:00:002019-09-11 00:00:00Past, Current, and Future of Immunotherapies for Prostate Cancer
